Completed PHASE2 INTERVENTIONAL 1-arm NCT00305929

Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure

Phase II Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure - Repeat Procedure

Sponsor: STEBA France

Conditions Prostate Cancer

Interventions Treatment with Tookad VTP

Updated 5 times since 2017 Last updated: May 31, 2010 Started: Mar 31, 2006 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Prostate Cancer, this trial is completed. The trial is conducted by STEBA France and has accumulated 5 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

STEBA France

Data source: STEBA France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada